Clinical Trial

Risk Markers of Arterial Aging. The Paris Prospective Study III-2

Study acronym: PPS3-2
Recruiting
View on ClinicalTrials.gov →
Summary
The main objectives of PPS3-2 are (i) to describe the dynamics of vascular aging and baroreflex sensitivity 12 to 16 years a part, (ii) to identify their determinants, and (iii) to quantify the subsequent risk of cardiovascular diseases.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-10-05; most recent amendment 2025-09-04.
Status change: Not Yet Recruiting → Recruiting 2025-09-04
Trial Details
NCT Number NCT06079424
Lead Sponsor Institut National de la Santé Et de la Recherche Médicale, France
Conditions Arterial Stiffness
Enrollment 7,500 participants
Start Date 2025-06-20
Primary Completion 2031-05 (estimated)
Study Completion 2033-12 (estimated)
Updated on ClinicalTrials.gov 2025-09-11